Multiple effects of the special AT‐rich binding protein 1 (SATB1) in colon carcinoma
Authors:
Open Access
- 12 April 2014
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 135 (11) , 2537-2546
Abstract
SATB1 (special AT‐rich binding protein 1) is a global chromatin organizer regulating the expression of a large number of genes. Overexpression has been found in various solid tumors and positively correlated with prognostic and clinicopathological properties. In colorectal cancer (CRC), SATB1 overexpression and its correlation with poor differentiation, invasive depth, TNM (tumor, nodes, metastases) stage and prognosis have been demonstrated. However, more detailed studies on the SATB1 functions in CRC are warranted. In this article, we comprehensively analyze the cellular and molecular role of SATB1 in CRC cell lines with different SATB1 expression levels by using RNAi‐mediated knockdown. Using siRNAs with different knockdown efficacies, we demonstrate antiproliferative, cell cycle‐inhibitory and proapoptotic effects of SATB1 knockdown in a SATB1 gene dose‐dependent manner. Tumor growth inhibition is confirmed in vivo in a subcutaneous tumor xenograft mouse model using stable knockdown cells. The in‐depth analysis of cellular effects reveals increased activities of caspases‐3, ‐7, ‐8, ‐9 and other mediators of apoptotic pathways. Similarly, the analysis of E‐ and N‐cadherin, slug, twist, β‐catenin and MMP7 indicates SATB1 effects on epithelial–mesenchymal transition (EMT) and matrix breakdown. Our results also establish SATB1 effects on receptor tyrosine kinases and (proto‐)oncogenes such as HER receptors and Pim‐1. Taken together, this suggests a more complex molecular interplay between tumor‐promoting and possible inhibitory effects in CRC by affecting multiple pathways and molecules involved in proliferation, cell cycle, EMT, invasion and cell survival.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (AI 24/9-1)
This publication has 43 references indexed in Scilit:
- Silencing SATB1 with siRNA inhibits the proliferation and invasion of small cell lung cancer cellsCancer Cell International, 2013
- Molecular correlates and prognostic significance of SATB1 expression in colorectal cancerDiagnostic Pathology, 2012
- Upregulation of SATB1 is associated with the development and progression of gliomaJournal of Translational Medicine, 2012
- A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancerBritish Journal of Cancer, 2012
- Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancerJournal of Ovarian Research, 2012
- Satb1 Ablation Alters Temporal Expression of Immediate Early Genes and Reduces Dendritic Spine Density during Postnatal Brain DevelopmentMolecular and Cellular Biology, 2012
- p63 regulates Satb1 to control tissue-specific chromatin remodeling during development of the epidermisJournal of Cell Biology, 2011
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivinMolecular Cancer, 2011
- Involvement of NF-κB/miR-448 regulatory feedback loop in chemotherapy-induced epithelial–mesenchymal transition of breast cancer cellsCell Death & Differentiation, 2010
- Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expressionGenes & Development, 2009